Disease Score gda Association Type Type Original DB Sentence supporting the association PMID PMID Year
Malignant neoplasm of colon and/or rectum
0.080 AlteredExpression disease BEFREE Our results suggest that DIM can influence the cell migratory and invasive properties of human colorectal cancer cells and may decrease the invasive capacity of colorectal cancer through downregulation of uPA and MMP9 mediated by suppression of the transcription factor FOXM1. 25962429 2015
Malignant neoplasm of colon and/or rectum
0.080 AlteredExpression disease BEFREE However, the contribution of uPAR expression in these stromal cells to malignancy and patient survival in colorectal cancer is still unclear. 24742002 2014
Malignant neoplasm of colon and/or rectum
0.080 AlteredExpression disease BEFREE Evaluation of alpha 1-antitrypsin and the levels of mRNA expression of matrix metalloproteinase 7, urokinase type plasminogen activator receptor and COX-2 for the diagnosis of colorectal cancer. 23300952 2013
Malignant neoplasm of colon and/or rectum
0.080 AlteredExpression disease BEFREE In mismatch repair-proficient colorectal cancer, overexpression of uPA and uPAR was associated with advanced pT stage (P = .009, both), an infiltrating margin (P = .009 and P = .033, respectively), and poor prognosis (P = .002 and P < .001, respectively). uPA, but not uPAR, maintained its significant prognostic effect in multivariable analysis (P = .037). 19740518 2010
Malignant neoplasm of colon and/or rectum
0.080 GeneticVariation disease BEFREE Antigen levels of urokinase-type plasminogen activator receptor and its gene polymorphism related to microvessel density in colorectal cancer. 18511987 2008
Malignant neoplasm of colon and/or rectum
0.080 Biomarker disease BEFREE Cathepsin B and L (CATB, CATL), urokinase-type plasminogen activator (uPA) and its inhibitor PAI-1 play an important role in colorectal cancer invasion. 18616803 2008
Malignant neoplasm of colon and/or rectum
0.080 GeneticVariation disease BEFREE Antigen levels of the urokinase-type plasminogen activator and its gene polymorphisms in colorectal cancer. 12430175 2002
Malignant neoplasm of colon and/or rectum
0.080 Biomarker disease BEFREE Urokinase-type plasminogen activator (uPA) is implicated in the control of cell adhesion and invasion, and is regarded as a strong prognostic marker in colorectal cancer. 11876553 2001